ArticleMolecules (Basel, Switzerland)2023

Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease.

Maxime Gagnon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.